73 related articles for article (PubMed ID: 12127077)
21. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies.
Kim KJ; Li B; Houck K; Winer J; Ferrara N
Growth Factors; 1992; 7(1):53-64. PubMed ID: 1380254
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells.
Fiebich BL; Jäger B; Schöllmann C; Weindel K; Wilting J; Kochs G; Marmé D; Hug H; Weich HA
Eur J Biochem; 1993 Jan; 211(1-2):19-26. PubMed ID: 7678805
[TBL] [Abstract][Full Text] [Related]
23. Generation of a novel proteolysis resistant vascular endothelial growth factor165 variant by a site-directed mutation at the plasmin sensitive cleavage site.
Lauer G; Sollberg S; Cole M; Krieg T; Eming SA
FEBS Lett; 2002 Nov; 531(2):309-13. PubMed ID: 12417332
[TBL] [Abstract][Full Text] [Related]
24. Effects of coronary artery disease on expression and microvascular response to VEGF.
Métais C; Li J; Li J; Simons M; Sellke FW
Am J Physiol; 1998 Oct; 275(4):H1411-8. PubMed ID: 9746492
[TBL] [Abstract][Full Text] [Related]
25. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis.
Jia H; Lohr M; Jezequel S; Davis D; Shaikh S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 May; 283(2):469-79. PubMed ID: 11327725
[TBL] [Abstract][Full Text] [Related]
26. Still more debate over VEGF.
Isner JM
Nat Med; 2001 Jun; 7(6):639-41. PubMed ID: 11385475
[No Abstract] [Full Text] [Related]
27. Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells.
Ferrara N; Winer J; Burton T; Rowland A; Siegel M; Phillips HS; Terrell T; Keller GA; Levinson AD
J Clin Invest; 1993 Jan; 91(1):160-70. PubMed ID: 8423215
[TBL] [Abstract][Full Text] [Related]
28. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
29. A novel method to purify recombinant vascular endothelial growth factor (VEGF121) expressed in yeast.
Mohanraj D; Olson T; Ramakrishnan S
Biochem Biophys Res Commun; 1995 Oct; 215(2):750-6. PubMed ID: 7488018
[TBL] [Abstract][Full Text] [Related]
30. High-affinity VEGF antagonists by oligomerization of a minimal sequence VEGF-binding domain.
Stefano JE; Bird J; Kyazike J; Cheng AW; Boudanova E; Dwyer M; Hou L; Qiu H; Matthews G; O'Callaghan M; Pan CQ
Bioconjug Chem; 2012 Dec; 23(12):2354-64. PubMed ID: 23176598
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
Goto F; Goto K; Weindel K; Folkman J
Lab Invest; 1993 Nov; 69(5):508-17. PubMed ID: 8246443
[TBL] [Abstract][Full Text] [Related]
32. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells.
Watanabe Y; Lee SW; Detmar M; Ajioka I; Dvorak HF
Oncogene; 1997 May; 14(17):2025-32. PubMed ID: 9160882
[TBL] [Abstract][Full Text] [Related]
33. Single-chain vascular endothelial growth factor variant with antagonist activity.
Boesen TP; Soni B; Schwartz TW; Halkier T
J Biol Chem; 2002 Oct; 277(43):40335-41. PubMed ID: 12151391
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
[TBL] [Abstract][Full Text] [Related]
35. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
[TBL] [Abstract][Full Text] [Related]
36. Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site.
Fairbrother WJ; Christinger HW; Cochran AG; Fuh G; Keenan CJ; Quan C; Shriver SK; Tom JY; Wells JA; Cunningham BC
Biochemistry; 1998 Dec; 37(51):17754-64. PubMed ID: 9922141
[TBL] [Abstract][Full Text] [Related]
37. The cystine knot promotes folding and not thermodynamic stability in vascular endothelial growth factor.
Muller YA; Heiring C; Misselwitz R; Welfle K; Welfle H
J Biol Chem; 2002 Nov; 277(45):43410-6. PubMed ID: 12207021
[TBL] [Abstract][Full Text] [Related]
38. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1.
LeCouter J; Moritz DR; Li B; Phillips GL; Liang XH; Gerber HP; Hillan KJ; Ferrara N
Science; 2003 Feb; 299(5608):890-3. PubMed ID: 12574630
[TBL] [Abstract][Full Text] [Related]
39. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
40. [Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors].
Werther K; Nielsen HJ
Ugeskr Laeger; 2000 Sep; 162(37):4916-20. PubMed ID: 11002739
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
